BioXcel Therapeutics (NASDAQ: BTAI)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of BioXcel Therapeutics (NASDAQ: BTAI) through any online brokerage.
The latest price target for BioXcel Therapeutics (NASDAQ: BTAI) was reported by Cantor Fitzgerald on Friday, August 12, 2022. The analyst firm set a price target for 4.00 expecting BTAI to fall to within 12 months (a possible -74.42% downside). 50 analyst firms have reported ratings in the last year.
The stock price for BioXcel Therapeutics (NASDAQ: BTAI) is $15.64 last updated August 12, 2022, 8:00 PM UTC.
The next BioXcel Therapeutics (BTAI) dividend date is projected to be Thursday, September 1, 2022.
BioXcel Therapeutics’s FY earnings are confirmed for Wednesday, December 20, 2023.
There is no upcoming split for BioXcel Therapeutics.
BioXcel Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.